# FDA Inspection 1122448 - Amryt Pharmaceuticals, Inc. - January 23, 2020

Source: https://www.keypedia.com/records/fda_inspections/amryt-pharmaceuticals-inc/ea72e082-e7f6-4428-b809-fae7e3ab5b9f
Source feed: FDA_Inspections

> FDA Inspection 1122448 for Amryt Pharmaceuticals, Inc. on January 23, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122448
- Company Name: Amryt Pharmaceuticals, Inc.
- Inspection Date: 2020-01-23
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1180597 - 2022-09-14](https://www.keypedia.com/records/fda_inspections/amryt-pharmaceuticals-inc/2496a4e5-0b59-4c86-a053-60e8af42815c)
- [FDA Inspection 947089 - 2015-07-16](https://www.keypedia.com/records/fda_inspections/amryt-pharmaceuticals-inc/bbd0d1a7-4a50-4861-b85c-b447fe5011c2)
- [FDA Inspection 947089 - 2015-07-16](https://www.keypedia.com/records/fda_inspections/amryt-pharmaceuticals-inc/7494d87e-0b14-4ebd-84d9-3d162baf311b)
- [FDA Inspection 797858 - 2012-08-27](https://www.keypedia.com/records/fda_inspections/amryt-pharmaceuticals-inc/2473246c-428c-4249-a14b-b9f1d381fad9)

Company: https://www.keypedia.com/companies/amryt-pharmaceuticals-inc/bfdef8ed-47d6-408f-a59b-16c2f17d796a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c